Physician profile
Lisa Park
NPI 1356401228
$8,049.00
in general payments reported to CMS, 2019-2025
13 companies · $475 in 2025
The $475 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $783 · 2020: $89.66 · 2022: $1,242 · 2023: $4,263 · 2024: $1,196 · 2025: $475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Charitable Contribution: $1,851 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500 · Travel and Lodging: $1,481 · Food and Beverage: $1,103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Charitable Contribution | $1,850.86 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
| Travel and Lodging | $1,480.55 |
| Food and Beverage | $1,102.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $5,520.12 | 2019-2025 | Clareon, Ngenuity, Tryptyr |
| Microsurgical Technology, INC. | $1,850.86 | 2023-2024 | |
| Johnson & Johnson Surgical Vision, INC. | $138.35 | 2025 | Tecnis Simplicity |
| Rxsight INC | $120.75 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $94.08 | 2024-2025 | Xdemvy |
| Abbvie INC. | $93.83 | 2025 | |
| Bausch & Lomb Americas INC. | $78.53 | 2024-2025 | Miebo, Xiidra |
| Bayer Healthcare Pharmaceuticals INC. | $39.53 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $32.91 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $24.43 | 2020 | |
| Eyevance Pharmaceuticals LLC | $20.13 | 2019 | |
| Ocular Therapeutix, INC. | $17.90 | 2020 | |
| Sun Pharmaceutical Industries INC. | $17.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.